Abbott Laboratories (ABT)
-NYSE 37.06 
0.17(0.46%) 4:02PM EDT|After Hours
:
37.07 0.01 (0.03%) 5:50PM EDT
| Prev Close: | 36.89 |
|---|
| Open: | 36.93 |
|---|
| Bid: | 36.84 x 300 |
|---|
| Ask: | 37.14 x 1100 |
|---|
| 1y Target Est: | 39.76 |
|---|
| Beta: | 0.52 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 36.83 - 37.15 |
|---|
| 52wk Range: | 28.46 - 37.55 |
|---|
| Volume: | 4,202,763 |
|---|
| Avg Vol (3m): | 8,001,080 |
|---|
| Market Cap: | 58.21B |
|---|
| P/E (ttm): | 11.30 |
|---|
| EPS (ttm): | 3.28 |
|---|
| Div & Yield: | 0.56 (1.50%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- China's Parents Crave Illegally Imported Baby Formulaat BusinessWeek(Thu 3:47PM EDT)
- Is Abbott a Good Defensive Play?at Wall St. Cheat Sheet(Thu 8:52AM EDT)
- At These Levels, Covidien Has Room To Runat Seeking Alpha(Tue, Apr 30)
- Abbott Laboratories Stock Is Half What It Used to Beat Motley Fool(Tue, Apr 30)
- Apple prices $17 bln bond deal to strong demandat MarketWatch(Tue, Apr 30)
- Building a Stronger Core With Abbott Laboratoriesat Motley Fool(Tue, Apr 30)
- Zoetis Beats, Pfizer Misses In Dual Q1 Reportsat Investor's Business Daily(Tue, Apr 30)
- [$$] Pfizer Still an Easy Pill to Swallowat Barrons.com(Tue, Apr 30)
- You Don’t Have to Run a Cartel to Make Big Profits in Drugsat Motley Fool(Tue, Apr 30)
- [$$] Sale of Brazil Drug Maker Stallsat The Wall Street Journal(Tue, Apr 30)
- The Foundations of the Pharmaceutical Industryat Motley Fool(Tue, Apr 30)
- Not All Dividend Increases Are The Same: 2 Dividend Trends That Can Make A Differenceat Seeking Alpha(Tue, Apr 30)
- UPDATE 2-U.S. task force calls for routine HIV testing for all adultsat Reuters(Mon, Apr 29)
- UPDATE 1-Task force calls for routine HIV testing for all adultsat Reuters(Mon, Apr 29)
- 'Ultimate' Stock Picker's Favorite Namesat CNBC(Mon, Apr 29)
Key Statistics
| Forward P/E (1 yr): | 16.47 |
|---|
| P/S (ttm): | 1.45 |
|---|
| Ex-Dividend Date: | 11-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.01 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.44 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.43 |
|---|
Business Summary
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine ins...
View More